SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-028073
Filing Date
2018-11-07
Accepted
2018-11-07 16:33:35
Documents
68
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q achv-10q_20180930.htm 10-Q 1506957
2 EX-3.1 achv-ex31_529.htm EX-3.1 4160
3 EX-10.1 achv-ex101_450.htm EX-10.1 350404
4 EX-31.1 achv-ex311_9.htm EX-31.1 9051
5 EX-31.2 achv-ex312_7.htm EX-31.2 9087
6 EX-32.1 achv-ex321_8.htm EX-32.1 4847
7 EX-32.2 achv-ex322_6.htm EX-32.2 4872
  Complete submission text file 0001564590-18-028073.txt   6646558

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT achv-20180930.xml EX-101.INS 1247946
9 XBRL TAXONOMY EXTENSION SCHEMA achv-20180930.xsd EX-101.SCH 58204
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE achv-20180930_cal.xml EX-101.CAL 56014
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE achv-20180930_def.xml EX-101.DEF 222737
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE achv-20180930_lab.xml EX-101.LAB 433359
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE achv-20180930_pre.xml EX-101.PRE 349972
Mailing Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101
Business Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 033-80623 | Film No.: 181166810
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Assistant Director 1